Literature DB >> 31185758

Ritonavir and cobicistat as pharmacokinetic enhancers in pregnant women.

Ahizechukwu C Eke1,2, Mark Mirochnick3.   

Abstract

Entities:  

Keywords:  Pharmacoenhancers; cobicistat; pregnancy; ritonavir

Mesh：

Substances：

Year:  2019        PMID： 31185758      PMCID： PMC9210948          DOI： 10.1080/17425255.2019.1628947

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN： 1742-5255            Impact factor:   4.936


× No keyword cloud information.
  9 in total

1.  Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?

Authors:  D Metsu; P L Toutain; E Chatelut; P Delobel; P Gandia
Journal:  J Antimicrob Chemother       Date:  2017-09-01       Impact factor: 5.790

2.  Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint.

Authors:  Sarita D Boyd; Mario R Sampson; Prabha Viswanathan; Kimberly A Struble; Vikram Arya; Adam I Sherwat
Journal:  AIDS       Date:  2019-05-01       Impact factor: 4.177

3.  Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV.

Authors:  Jeremiah D Momper; Brookie M Best; Jiajia Wang; Edmund V Capparelli; Alice Stek; Emily Barr; Martina L Badell; Edward P Acosta; Murli Purswani; Elizabeth Smith; Nahida Chakhtoura; Kyunghun Park; Sandra Burchett; David E Shapiro; Mark Mirochnick
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

Review 4.  Pharmacokinetic enhancement in HIV antiretroviral therapy: a comparison of ritonavir and cobicistat.

Authors:  Boris Renjifo; Jean van Wyk; Ahmed Hamed Salem; Daniel Bow; Juki Ng; Michael Norton
Journal:  AIDS Rev       Date:  2015 Jan-Mar       Impact factor: 2.500

5.  Designing drug trials: considerations for pregnant women.

Authors:  Jeanne S Sheffield; David Siegel; Mark Mirochnick; R Phillips Heine; Christine Nguyen; Kimberly L Bergman; Rada M Savic; Jill Long; Kelly E Dooley; Mirjana Nesin
Journal:  Clin Infect Dis       Date:  2014-12-15       Impact factor: 9.079

6.  Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women.

Authors:  Alice Stek; Brookie M Best; Jiajia Wang; Edmund V Capparelli; Sandra K Burchett; Regis Kreitchmann; Kittipong Rungruengthanakit; Tim R Cressey; Lynne M Mofenson; Elizabeth Smith; David Shapiro; Mark Mirochnick
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

7.  Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications.

Authors:  Catia Marzolini; Sara Gibbons; Saye Khoo; David Back
Journal:  J Antimicrob Chemother       Date:  2016-03-05       Impact factor: 5.790

8.  Pharmacologic Research in Pregnant Women - Time to Get It Right.

Authors:  Ahizechukwu C Eke; Kelly E Dooley; Jeanne S Sheffield
Journal:  N Engl J Med       Date:  2019-04-04       Impact factor: 176.079

Review 9.  Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations.

Authors:  Alice Ban Ke; Rick Greupink; Khaled Abduljalil
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-01-31
  9 in total
  7 in total

Review 1.  Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy.

Authors:  Engie Salama; Ahizechukwu C Eke; Brookie M Best; Mark Mirochnick; Jeremiah D Momper
Journal:  J Clin Pharmacol       Date:  2020-08-14       Impact factor: 3.126

Review 2.  Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy.

Authors:  Amanda J Jones; Uzoamaka A Eke; Ahizechukwu C Eke
Journal:  Expert Rev Anti Infect Ther       Date:  2022-03-01       Impact factor: 5.854

3.  Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy.

Authors:  Ahizechukwu C Eke; Jiajia Wang; Khadija Amin; David E Shapiro; Alice Stek; Elizabeth Smith; Nahida Chakhtoura; Michael Basar; Kathleen George; Katherine M Knapp; Esaú C João; Kittipong Rungruengthanakit; Edmund Capparelli; Sandra Burchett; Mark Mirochnick; Brookie M Best
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 4.  Drug-Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?

Authors:  Vera E Bukkems; Angela Colbers; Catia Marzolini; Jose Molto; David M Burger
Journal:  Clin Pharmacokinet       Date:  2020-10       Impact factor: 6.447

5.  Darunavir Pharmacokinetics With an Increased Dose During Pregnancy.

Authors:  Ahizechukwu C Eke; Alice M Stek; Jiajia Wang; Regis Kreitchmann; David E Shapiro; Elizabeth Smith; Nahida Chakhtoura; Edmund V Capparelli; Mark Mirochnick; Brookie M Best
Journal:  J Acquir Immune Defic Syndr       Date:  2020-04-01       Impact factor: 3.771

Review 6.  Tenofovir alafenamide use in pregnant and lactating women living with HIV.

Authors:  Ahizechukwu C Eke; Kristina M Brooks; Rahel D Gebreyohannes; Jeanne S Sheffield; Kelly E Dooley; Mark Mirochnick
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-03-17       Impact factor: 4.936

7.  Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement.

Authors:  Ahizechukwu C Eke; Adeniyi Olagunju; Jeremiah Momper; Martina Penazzato; Elaine J Abrams; Brookie M Best; Edmund V Capparelli; Adrie Bekker; Yodit Belew; Jennifer J Kiser; Kimberly Struble; Graham Taylor; Catriona Waitt; Mark Mirochnick; Tim R Cressey; Angela Colbers
Journal:  Clin Pharmacol Ther       Date:  2020-10-15       Impact factor: 6.875
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.